ETFs Holding VNDA »    VNDA Historical Stock Prices »
VNDA News Video: Wed, Jun 4, 2014, 3:23 PM — Wednesday's ETF Movers: XBI, GXC

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Vanda Pharmaceuticals is a biopharmaceutical company. Co.'s product portfolio includes: HETLIOZ®, a product for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) as well as for the treatment of Non-24 in totally blind adults; Fanapt®, a product for the treatment of schizophrenia; Tradipitant, a small molecule neurokinin-1 receptor, which is in clinical development for the treatment of chronic pruritus in atopic dermatitis and gastroparesis; VTR-297, a small molecule histone deacetylase inhibitor which is in development for the treatment of hematologic malignancies; and VQW-765, a Phase II alpha-7 nicotinic acetylcholine receptor partial agonist. Self directed investors in Vanda Pharmaceuticals Inc will be interested in keeping up with all Vanda Pharmaceuticals Inc news they can find, both VNDA news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on VNDA. At RediNews, we simplify this task by presenting both VNDA news releases originating from Vanda Pharmaceuticals Inc itself, and VNDA news from a variety of media outlets. Visitors can browse this news online and through our VNDA RSS news feed.


VNDA News — Articles, Videos, & Press Releases

Vanda Pharmaceuticals Becomes Oversold (VNDA)
Wednesday, April 17, 2019, 12:01 PM — Dividend Channel
Short Interest In Vanda Pharmaceuticals Makes 19.7% Move
Wednesday, April 10, 2019, 11:54 AM — Market News Video
First Week of May 17th Options Trading For Vanda Pharmaceuticals (VNDA)
Tuesday, March 19, 2019, 11:46 AM — Stock Options Channel
Implied SLY Analyst Target Price: $76
Tuesday, March 19, 2019, 7:27 AM — ETF Channel
Relative Strength Alert For Vanda Pharmaceuticals
Wednesday, March 6, 2019, 11:54 AM — Dividend Channel
Vanda Pharmaceuticals (VNDA) Tops Q4 Earnings and Revenue Estimates
Wednesday, February 13, 2019, 4:25 PM — Zacks
VNDA Crosses Below Key Moving Average Level
Wednesday, February 6, 2019, 12:03 PM — Market News Video
Oversold Conditions For Vanda Pharmaceuticals (VNDA)
Wednesday, February 6, 2019, 12:02 PM — Dividend Channel
5 Stocks With Recent Price Strength Despite Volatile Market
Wednesday, January 16, 2019, 5:59 AM — Zacks
Analysts Expect RZG Will Reach $136
Monday, January 14, 2019, 8:07 AM — ETF Channel
First Week of February 15th Options Trading For Vanda Pharmaceuticals (VNDA)
Friday, January 4, 2019, 10:35 AM — Stock Options Channel
Add Up The Parts: IJT Could Be Worth $209
Wednesday, December 12, 2018, 8:12 AM — ETF Channel
Vanda Pharmaceuticals Reaches Analyst Target Price
Tuesday, December 4, 2018, 8:00 AM — ETF Channel
Noteworthy Monday Option Activity: GM, AMWD, VNDA
Monday, December 3, 2018, 3:20 PM — Stock Options Channel
First Week of January 2019 Options Trading For Vanda Pharmaceuticals (VNDA)
Wednesday, November 21, 2018, 11:23 AM — Stock Options Channel
Short Interest Moves 89% Higher For VNDA
Thursday, October 25, 2018, 10:27 AM — Market News Video
How The Parts Add Up: FYX Targets $75
Wednesday, October 24, 2018, 8:11 AM — ETF Channel
Analysts Expect 15% Upside For IHE
Thursday, August 30, 2018, 7:38 AM — ETF Channel
Implied PBE Analyst Target Price: $64
Friday, July 27, 2018, 7:25 AM — ETF Channel
Interesting VNDA Put And Call Options For August 17th
Monday, June 25, 2018, 10:46 AM — Stock Options Channel
Analysts Anticipate PBE To Hit $60
Monday, June 18, 2018, 7:34 AM — ETF Channel
Vanda Pharmaceuticals Stock Sees Short Interest Drop 11%
Friday, May 25, 2018, 2:06 PM — Market News Video
Analysts Predict 27% Gains Ahead For IHE
Wednesday, May 16, 2018, 8:29 AM — ETF Channel
Vanda Pharmaceuticals Stock Sees Short Interest Make 16.5% Move
Thursday, May 10, 2018, 3:36 PM — Market News Video
First Week of VNDA December 21st Options Trading
Friday, May 4, 2018, 10:39 AM — Stock Options Channel
VNDA is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:


If you use web portal software to control your web site content, chances are your portal software already makes it easy for you to integrate RSS feeds from third party sources, like RediNews. Using RSS — short for Really Simple Syndication — makes content syndication a snap, so even if you have never worked with a stock data feed before, you should still have no problem working with the content delivery mechanism made possible by RSS. These RediNews RSS feeds are found throughout our website wherever news is found, whether by sector or custom content by symbol, by clicking the RSS icon for any news page (which will look like this): .

VNDA News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.